Avia Logo

Compare Products


Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Product Capabilities
Use cases
EHR integrations
Client types
Awards
Differentiators
Keywords
Media
Company details
Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Product Capabilities
Use cases
EHR integrations
Client types
Awards
Differentiators
Keywords
Media
Company details

Categories

Solutions

Description

Product Description:

The Propeller Digital Therapeutic Platform

Propeller’s FDA-cleared digital therapeutic platform consists of Bluetooth-enabled sensors, a digital patient experience through mobile app or web portal, a clinician insights portal for remote monitoring, plus tailored patient support through virtual coaching. These components seamlessly integrate with one another to improve health outcomes for patients, and in turn, drive measurable clinical and business outcomes for healthcare organizations. Here’s how it works:

  1. PropellerConnect™ Sensors & Data Connectivity: Propeller sensors capture unique signals that passively record events, such as medication usage or respiration, and transmit data to Propeller via Bluetooth or hub connection. Sensors are compatible with more than 80% of inhaled medications on the U.S. market, including medications for MDI, Respimat®, Diskus®, Ellipta®, and Symbicort® inhalers.*
  2. MyPropeller™ Patient App & Portal: Sensor data is sent to the Propeller mobile app or online portal, empowering patients to learn about their breathing and triggers while delivering personalized, motivating journeys that build healthy habits.
  3. PropellerInsight™ Clinical Decision Support & Analytics: Via an EHR integration or our Clinician Portal, care teams can remotely monitor patients’ medication use and view on-demand reports to gain a clearer understanding of disease control status, symptoms, and triggers. These insights help inform clinical decisions and treatment plans, and enable proactive identification of patients who may be at a greater risk for an exacerbation and require timely clinical intervention.
  4. PropellerCare™ Support and Coaching: Propeller’s patient success team ensures users receive personalized support and coaching to help them confidently navigate the platform, stay focused on their goals, and take control of their breathing.

Propeller Health Solutions

Propeller configures its digital therapeutic platform into a variety of solutions that help healthcare and life sciences organizations meet their goals while navigating the shift to value-based care.

  • For Independent Physician Groups: Remote therapeutic monitoring programs to enhance care for eligible chronic patients
  • For Hospitals and Health Systems: Digital health programs for select clinics, target populations, or systemwide; integration into a service line/specialty for population health management
  • For Payers and Pharmacy Benefits Managers: Integration of digital health programs into existing care management or population health initiatives
  • For Life Sciences Organizations: Integration or co-packaging of digital companion (i.e., sensor, app, support) with connected drug delivery devices such as inhalers to support clinical trials, medication adherence, and biologics

---

*Respimat is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc. Diskus and Ellipta are registered trademarks of the GlaxoSmithKline group of companies. Symbicort is a registered trademark of the AstraZeneca group of companies.

About Propeller Health:

Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. We power motivating, care-connected patient journeys and unify value for all stakeholders – providers, health systems, payers, pharmaceutical companies, and other healthcare and life sciences organizations.

The Propeller Platform includes FDA-cleared and CE-marked medical devices, consumer apps, support, and secure access to clinical data for provider monitoring. Our precision approach motivates behavior change and tracks patient adherence that enables medication optimization, helping predict costly exacerbations. We set the scientific standard in digital-first chronic respiratory care through our peer-reviewed research demonstrating improved quality of life and clinical outcomes while lowering healthcare costs.

As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.

Product Description:

Babyscripts Virtual Maternity Care is a clinically-validated, obstetrics-specific solution that allows OB/GYNs and other maternal health care providers to deliver a new model of prenatal and postpartum care via a mobile app-based platform and remote patient monitoring experiences. 


Babyscripts exists to solve the problems generated from the critical shortage of obstetrical providers in the U.S. and to transform the delivery of pregnancy care through the power of technology and remote patient monitoring.


Babyscripts offers comprehensive virtual maternity care that, through managing various levels of risk, addresses an outdated model for pregnancy care that has not moved the needle in decreasing maternal morbidity and mortality; an inability to address social determinants of health; and the increasing decision to transition care outside of the clinic post-Covid.


The company’s solution for virtual maternity care manages the various risk-levels of a maternal health population to address some of the largest drivers of costs and complications in perinatal care. Babyscripts’ mobile app-based solution with remote monitoring experiences allows providers to deliver risk-specific care to pregnant mothers at any time, in any place.


The solution consists of a three-tiered approach. The first tier is a digital education layer prescribed by the provider and delivered to the patient via a mobile app, Babyscripts myJourney, with daily gestational-age and practice-specific, customizable content extending through one year postpartum, as well as weight tracking and management. By giving the patient 24/7 access to digital resources approved by their care provider, the app cuts down on misinformation found through internet sources, and also eliminates the need for clunky and expensive paper resources. Push notifications and reminders keep patients engaged with content. Providers can also develop and deploy customized campaigns to segmented populations through the mobile app. 


The second tier enables remote management of pregnant patients, specifically focused on mental health or blood pressure-related risk. These remote monitoring solutions help to resolve barriers of distance for mothers who are living in maternity care deserts or otherwise struggling with barriers to access. 


Babyscripts blood pressure monitoring, myBloodPressure, enables comprehensive and intelligent monitoring and intervention across four risk-specific categories (including low-risk, chronic hypertension, prenatal hypertension, and postpartum hypertension). This program collects patient-generated biometric data from a bluetooth-connected or manual blood pressure cuff through the Babyscripts myJourney app and communicates it back to the care team, allowing providers to identify elevated risks remotely. Providers set trigger protocols for each risk category to enable a risk-stratified response. If a patient records an elevated or critical blood pressure reading, the unique trigger system activates a response to the patient from a 24/7 call center, and alerts providers to patient risk immediately, enabling real-time interventions and risk management. 


Babyscripts' maternal mental health monitoring, myMentalHealth, prompts patients to assess their mental state through risk surveys delivered via the mobile app. Based on patient responses, providers and care team are alerted to patient risk and patients are connected to necessary resources. In addition to intelligent mental health reporting features, patients have access to mental health education information and exercises for mindfulness and meditation. 


The third tier brings the insurer into the equation in a collaboration between care team and payer focused on population health, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost. Payers sponsor the cost of Babyscripts for their members at participating hospitals to identify pregnancy earlier, detect risk faster, connect members to local resources, and reduce poor outcomes like C-sections and preterm birth, among other risks. Checklists delivered in the app keep members engaged and allow providers to track compliance with certain quality measures.


Babyscripts partnered with GW-MFA and others in a number of research projects, with results published in ACOG’s Green Journal and JMIR, validating the effectiveness of reduced in-person visits for prenatal care, better management of weight and blood pressure complications, improving compliance and adherence to HEDIS measures, and reducing rates of readmission in the postpartum period through remote monitoring. The results from many of these studies have been referenced in several new publications related to COVID-19, as health systems have been forced to transition care outside of the clinic and rethink the traditional prenatal care model.


Babyscripts' patient-centric solution extends care outside the four walls of the office, making personalized healthcare education, risk-stratified remote monitoring, and real-time virtual triage as readily accessible as the smartphone, responding to mothers’ needs for accessibility and convenience. Babyscripts has deeply engaged this patient population, with 92% of users saying that they would recommend the solution to their friends.


Babyscripts' vision for improving care has always been driven and amplified by clinicians: strategic partners like George Washington Medical Faculty Associates, Cone Health System, and Advocate Aurora Healthcare, among others. These partnerships are essential to Babyscripts' project of creating solutions for patients with and for clinicians.


Babyscripts alone is aimed at and connected to obstetrical providers to create more engagement, detection and efficiency in treating their patients. Babyscripts is the only digital platform that gives the provider and payer the ability to monitor both behavioral compliance and physical vital signs between visits, to identify adverse trends in real-time and lower the cost of care. The ability to integrate Babyscripts into the Medical Record and clinical workflow is one of its most important value-adds, allowing providers to offer comprehensive virtual care and payers to deliver “next generation” care coordination.

About Babyscripts:

Babyscripts is delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. Since 2014, Babyscripts has offered the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. For more information on our virtual care solution and to request a demo, visit babyscripts.com.

Compatibility level

Select which hospital or health system you work at and see a personalized compatibility level.

Clients

Select which hospital or health system you work at and see the client list

Product Capabilities

Our sensors attach to patients’ existing inhalers, reminding patients to take their medications on time and automatically tracking medication use data. This information is sent wirelessly to a patient’s mobile app or web portal account, helping them learn about their symptoms, triggers, and medication use habits (including when, where, and how often they dose). Clinicians can easily access this important data, too — either by using the Propeller Clinician Portal or through an integration with their EHR.

Propeller takes the guesswork out of understanding patient adherence and disease control. Between visits, clinicians can receive notifications when patients have not been adherent to controller medication or when rescue medication use increases significantly, helping them proactively identify and intervene with their most at-risk patients, and enabling health systems and hospitals to focus finite resources on patients who need it most.

Propeller expands access to our platform and helps overcome literacy challenges through the use of appropriate reading levels for different audiences, based on the Flesch-Kincaid scale. Our platform, including our patient-facing mobile app and web portal, is available in 16 different languages. Additionally, patients without access to mobile devices or internet service can still experience all the benefits of Propeller with a cellular hub — a smartphone alternative offered through clinical and commercial programs. The hubs simply plug into a wall outlet, passively capture medication use, and seamlessly transmit that data to the patient’s provider.

One component of Propeller’s digital therapeutic platform is PropellerCare™, in which our patient success team ensures users receive personalized support and coaching to help them confidently navigate the platform, stay focused on their goals, and take control of their breathing. By surrounding patients with continuous support and care connections, they become more engaged in self-managing their condition and stay motivated to take actions that will largely impact their overall health.

Propeller offers patients two primary delivery options when it comes to engagement: a mobile app and a web portal (desktop or tablet). With either option, patients can view their medication use data on-demand, track their symptoms and triggers, and access personalized, educational content to learn more about their conditions.

In addition to personalized environmental insights such as air quality, the Propeller platform offers tailored educational content to help patients learn more about their conditions, personalized tips for self-management, and custom insights based on a patient’s medication use trends. For example, the mobile app can preemptively advise patients to consult with their providers when a significant increase in rescue medication use is detected.

Our suite of 10+ FDA and CE cleared devices cover more than 80% of all inhaled medications on the market. These devices/sensors snap onto patients’ existing inhalers, passively record medication events, and seamlessly transmit that data to a patient-facing mobile app or web portal for on-demand viewing.

When it comes to providers and clinicians, one of the biggest considerations we’ve kept in mind when developing our platform is ensuring that it is simple to use. Providers may not have as much time as they’d like to routinely check patient data. Our platform is designed such that there are several ways for providers and clinicians to receive critical patient data for clinical decision making, without the need to log in to another website or portal. For example, providers can elect to receive daily email notifications informing them of patients who are not adherent or may be overusing their rescue medications. For providers with an EHR integration, custom dot-phrases make it easy to pull patient data from their charts. At any time, Propeller’s clinician (and patient) support teams are available to answer any questions regarding training, onboarding, and technical support.

The Propeller Digital Therapeutic Platform can integrate into leading EHR platforms — including Cerner and Epic (via Redox) — making it easier for clinical staff to receive objective patient data and enhanced clinical decision support, all within their native workflows. The implementation process can take 12-16 weeks, depending on the program design and the organization’s governance structure.

Use Cases

Description:

For more than 10 years, the effectiveness of Propeller has been demonstrated across diverse geographies, clinical settings, and patient populations. Our digital therapeutic platform has been utilized in 80+ commercial programs and research studies, involving more than 6,000 study participants and resulting in more than 150 peer-reviewed publications and abstracts. Our platform is clinically proven to improve quality of life and patient outcomes, including:

  • Up to 58% improvement in medication adherence [1]
  • Up to 35% reduction in COPD-related healthcare utilization [2]
  • Up to 57% reduction in asthma-related healthcare utilization [3]
  • Up to 18.5% reduction in asthma-related rescue inhaler use, compared to a control group [4]

---

Sources: [1] Van Sickle et al. 2016, Eur Resp J. [2] Alshabani et al. 2019, J Telemedicine and Telecare. [3] Merchant et al. 2018, World Allergy Organ J. [4] Barrett et al. 2018, Health Aff.

Pediatric use cases:

Propeller has participated in a variety of pediatric asthma program types, from high-touch clinical interventions to real-world, practice-based programs. Our platform is clinically proven to decrease rescue inhaler use by 75%* and reduce symptoms and exacerbations** among pediatric users.

---

* Carl et al. 2018, American Thoracic Society.

** Lin et al. 2020, Pediatric Pulmonology.

Users:

Patients, caregivers of patients, and clinicians

Description:

Babyscripts is appropriate for pregnant and postpartum mothers of any risk category. Through a digital education layer delivered via a mobile app and connected devices that communicate biometric, mental health, and sociological data back to the provider, Babyscripts targets issues such as preeclampsia, weight gain, hypertension, mental health, and social barriers such as access to care.

Pediatric use cases:

Babyscripts offers postpartum support up through one year post-childbirth.

Users:

OBGYNS, midwives, RNs, payers, social workers, care managers, case managers, primary care deliver our solution to pregnant and postpartum patients/members.

EHR Integrations

Integrations:

Pop health platform

EMR Integration & Relevant Hardware:

Use case dependent

EMRs Supported:

Cerner, Epic

Hardware Compatibility:

Desktop

Integrations:

Ambulatory EMR, Credentialing, Website / public online sources, Other

EMR Integration & Relevant Hardware:

Recommended, but not required

EMRs Supported:

Epic, athena, Cerner, Allscripts, eClinicalWorks

Hardware Compatibility:

Desktop, Mobile / Tablet (web optimized), Mobile / Tablet (native app)

Client Types

Awards

edit-media
edit-media
edit-media
edit-media
edit-media
edit-media
edit-media
edit-media
edit-media

Differentiators

Differentiators vs EHR Functionality:

To learn about how Propeller differentiates from other options in this space, please reach out to info@propellerhealth.com. 

Differentiators vs Competitors:

As a leading precision digital health company, Propeller Health differs from others in the industry in that:  

  • Our 10+ FDA and CE cleared devices cover more than 80% of all inhaled medications on the market – and our capabilities go far beyond respiratory care.
  • We have conducted 80+ commercial programs and research studies, and a body of research no other digital health company can match: more than 150 peer-reviewed publications and abstracts.
  • Our parent company has decades of experience bringing specialized medical devices to market in more than 140 countries. Together, our regulatory expertise, logistics support, engineering and component sourcing knowledge is unmatched.
  • We have unique experience partnering with and unifying value for stakeholders across the healthcare ecosystem: independent clinics, hospitals and health systems, payers and PBMs, pharmaceutical and life sciences companies, as well as patients and clinicians. 

---

Our FDA-cleared digital therapeutic platform stands apart from other digital health solutions in that: 

  • It is used by a broad spectrum of patients from pediatric (asthma) to elderly (COPD), and is proven effective in engaging underserved and vulnerable patient populations (Medicaid, Medicare). 
  • It engages patients with COPD — an often difficult to engage patient population — earlier in their care (stages 1 and 2). For patients whose conditions continue to progress, they can receive care in later stages (3 and 4) with solutions from our parent company, ResMed.
Differentiators vs EHR Functionality:
  1. Babyscripts has exclusively licensed best-in-class protocols that allow the company to make categorical claims in the market around efficacy and outcomes.
  2. The Babyscripts solution has been clinically-validated through peer reviewed research and case studies proving efficacy in schedule optimization, patient engagement, and other outcomes.
  3. Babyscripts has a wealth of its own IP in managing patients remotely (like maintaining compliance) and in detecting and triaging abnormal data points to reduce false positives and elevate real problems.
  4. While some health systems might invest in specific component parts of what Babyscripts typically offers (an app or integrating data points from IOT devices back to the record), the real challenge is in scaling programs and offering the right protocol at the point of care to generate ROI. Babyscripts is the expert in remote obstetrical care and since 2014 has accumulated a wealth of collateral, assets and best practices that enable these programs to scale.
  5. Babyscripts is a scaled program that is significantly less expensive to implement and use than a health system trying to build and maintain their own program. Babyscripts represents a lower cost for health systems to develop, deploy and maintain, with the added benefit of continuous technical and customer support managed by Babyscripts.
Differentiators vs Competitors:
  1. Babyscripts offers the only clinically-validated, obstetrics-specific mobile platform that delivers educational information that aligns with a provider's care plan. While other maternity programs deliver evidence-based content, only Babyscripts allows the provider to customize their content, delivering the exact information that they want the patient to see and eliminating confusion. 
  2. Babyscripts deploys internet-enabled medical devices that directly triage information like high blood pressure back to the physician automatically in their desired workflow, a solution that no consumer app provides. Because of the connection with the provider, Babyscripts detects abnormal trends and then triages those data points directly to the provider’s office. With Babyscripts’ risk-specific modules, a provider is able to deliver different clinical experiences to patients dependent on risk. Babyscripts provides the only clinically-validated solution to focus on obstetrics. 
  3. Babyscripts is the first obstetrics-specific digital solution to connect payers and providers, improving care coordination for maternal health populations, monitoring adherence to quality measures, and improving patient engagement and outcomes. This solution helps mothers overcome barriers to care by assessing for risk, providing mothers with direct access to resources directly correlated with their identified risks.


Keywords

Images

1 of 4

edit-media
Propeller Sensor and Mobile App

1 of 1

edit-media
Babyscripts_kit_1_2.jpg

Videos

1 of 2

edit-media
Introduction to Propeller Health

1 of 2

edit-media

Downloads

No content provided

Alternatives

Company Details

Founded in 2007

Founded in 2014

Need help narrowing down products?

Add more criteria to see your compatibility level for every vendor. It only takes a few minutes, just create a free account to get started.
back to top